Table 2. Association between clinical parameters and baseline (pre-ablation) von Willebrandt factor levels.
vWF FV_pre | vWF LA_pre | |||||||
Variables | UV | MV | UV | MV | ||||
Beta | p-value | Beta | p-value | Beta | p-value | Beta | p-value | |
Age | −.099 | 0.386 | .031 | 0.788 | ||||
Persistent AF | .317 | 0.004 | .303 | 0.006 | .323 | 0.004 | .300 | 0.006 |
Female gender | .062 | 0.586 | .069 | 0.547 | ||||
Hypertension | .043 | 0.708 | .092 | 0.421 | ||||
Diabetes | .102 | 0.373 | .029 | 0.796 | ||||
CAD/PAD | .004 | 0.971 | .104 | 0.363 | ||||
BMI | .216 | 0.056 | .163 | 0.162 | .176 | 0.120 | .156 | 0.147 |
eGFR | .148 | 0.192 | .079 | 0.497 | −.004 | 0.971 | ||
LA diameter | .067 | 0.557 | .074 | 0.518 | ||||
EF | −.141 | 0.216 | .028 | 0.808 | ||||
Spontaneous contrast | .135 | 0.236 | .176 | 0.121 | .157 | 0.145 | ||
Oral anticoagulation | −.064 | 0.235 | −.093 | 0.415 |